Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Glycomine

Glycomine?uq=UG6efJS6
2013 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$12M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of nano medicines designed to develop a new generation of replacement therapies for rare diseases. The company's medicines include orphan drugs that combine replacement therapies - substrates, enzymes, or proteins - with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs, enabling physicians treat their patients with for serious rare monogenic disorders of metabolism and protein misfolding.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Glycomine’s full profile, request a free trial.

Glycomine Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 16-Nov-2016 $12M 0000 000.00 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Glycomine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

Glycomine Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Chiesi Ventures Corporate Venture Capital Minority 000 0000 000000 0
Pappas Capital Venture Capital Minority 000 0000 000000 0
Sanderling Ventures Venture Capital Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0

Glycomine Executive Team (3)

Name Title Board
Seat
Contact
Info
Agnes Rafalko Ph.D Founder, President, Board Member & Chief Executive Officer
Christopher Starr Ph.D Executive Chairman
Patrice Rioux Ph.D Chief Medical Officer

Glycomine Board Members (3)

Name Representing Role Since Contact
Info
Christopher Starr Ph.D Glycomine Executive Chairman 000 0000
Giacomo Chiesi Glycomine Board Member 000 0000
Peter McWilliams Glycomine Board Member 000 0000